Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written and followed.
Inspection Record
SciVac LTD — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Deviations from written production and process control procedures are not recorded or justified.
Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.
The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Alkem Laboratories Limited2024-03-27 · US FDASimilar to finding 4 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- Aqualex Co., Ltd.2023-10-20 · US FDASimilar to finding 4 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- Micro Labs Limited2025-02-07 · US FDASimilar to finding 4 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- ADMA Biologics, Inc2024-12-11 · US FDASimilar to finding 1 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written and followed.
- IntegraDose Compounding Services LLC2026-08-12 · US FDASimilar to finding 4 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.